Kiniksa Pharmaceuticals, Ltd. - (KNSA): Price and Financial Metrics


Kiniksa Pharmaceuticals, Ltd. - (KNSA)

Today's Latest Price: $17.95 USD

0.62 (3.58%)

Updated Feb 18 8:00pm

Add KNSA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

KNSA Daily Price Range
KNSA 52-Week Price Range

KNSA Stock Price Chart More Charts


KNSA Price/Volume Stats

Current price $17.95 52-week high $21.50
Prev. close $17.33 52-week low $5.01
Day low $17.33 Volume 113,400
Day high $18.15 Avg. volume 240,553
50-day MA $14.11 Dividend yield N/A
200-day MA $11.71 Market Cap 985.06M

Kiniksa Pharmaceuticals, Ltd. - (KNSA) Company Bio


Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its clinical-stage product candidates include Rilonacept, which is in Phase II clinical trials for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; and KPL-716, a monoclonal antibody, which is in Phase 1a/1b clinical trial for the treatment of prurigo nodularis and atopic dermatitis. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda


KNSA Latest News Stream


Event/TimeNews Detail
Loading, please wait...

KNSA Latest Social Stream


Loading social stream, please wait...

View Full KNSA Social Stream

KNSA Price Returns

1-mo N/A
3-mo 100.78%
6-mo 102.37%
1-year 1.76%
3-year N/A
5-year N/A
YTD 62.30%
2019 -60.63%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5646 seconds.